Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA known ✓ | P42336 | 1/20 | 0.48 |
| ▸ | GLA known ✓ | P06280 | 1/20 | 0.32 |
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.32 |
| ▸ | ACHE known ✓ | P22303 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.38 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL154618 | 1.00 | POLB (0.48) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| Hydrochloric Acid SCHEMBL6369794 | 1.00 | POLB (0.48) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL9667 | 0.97 | CYP3A4 (0.50) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL8504753 | 0.94 | POLB (0.48) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL3220414 | 0.94 | POLB (0.48) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| Hydrogen Peroxide SCHEMBL3335939 | 0.92 | POLB (0.46) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| Hydrochloric Acid SCHEMBL309540 | 0.87 | CYP3A4 (0.59) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| Hydrochloric Acid SCHEMBL529931 | 0.87 | CYP3A4 (0.59) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| Hydrochloric Acid SCHEMBL29566187 | 0.87 | CYP3A4 (0.59) | POLBCYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL29384787 | 0.84 | CYP3A4 (0.62) | POLBCYP3A4TSHRPIK3CAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112608976-A | Detection kit and detection method for periodontal pathogen infection marker | 珠海市德灏生物科技有限公司 | 2021-04-06 | — | — | CN | claimed |
| US-20120202236-A1 | COMPOSITE ANIMAL LITTER MATERIAL AND METHODS | 7905122 CANADA INC. (CA) | 2012-08-09 | — | — | US | claimed |
| EP-2433127-A1 | COMPOSITE ANIMAL LITTER MATERIAL AND METHODS | 7905122 Canada Inc. (CA) | 2012-03-28 | — | — | EP | claimed |
| WO-2010133001-A1 | COMPOSITE ANIMAL LITTER MATERIAL AND METHODS | LES PROCEDES SERVI-SAND CANADA INC (CA) | 2010-11-25 | — | — | WO | claimed |
| EP-1274999-B1 | METHOD AND TEST STRIP OF DETECTING OXIDIZING ADULTERANT IN URINE | BRANAN MEDICAL CORP (US) | 2010-11-17 | — | — | EP | claimed |
| EP-1274999-A4 | METHOD AND TEST STRIP OF DETECTING OXIDIZING ADULTERANT IN URINE | BRANAN MEDICAL CORP (US) | 2006-05-24 | — | — | EP | claimed |
| EP-1274999-A1 | METHOD AND TEST STRIP OF DETECTING OXIDIZING ADULTERANT IN URINE | Branan Medical Corp. (US) | 2003-01-15 | — | — | EP | claimed |
| WO-2001075444-A1 | METHOD AND TEST STRIP OF DETECTING OXIDIZING ADULTERANT IN URINE | BRANAN MEDICAL CORP. (US) | 2001-10-11 | — | — | WO | claimed |
| EP-0398941-A4 | DRY POWDER DIAGNOSTIC REAGENT AND APPLICATIONS THEREOF | — | 1991-04-10 | — | — | EP | claimed |
| EP-0398941-A1 | DRY POWDER DIAGNOSTIC REAGENT AND APPLICATIONS THEREOF | BOEHRINGER MANNHEIM CORPORATION (US) | 1990-11-28 | — | — | EP | claimed |
| WO-1989006284-A1 | DRY POWDER DIAGNOSTIC REAGENT AND APPLICATIONS THEREOF | BOEHRINGER MANNHEIM CORPORATION (US) | 1989-07-13 | — | — | WO | claimed |
| EP-0196743-A2 | Stable chemical compositions containing chromogenic materials and peroxides, and method for obtaining them | SAVYON DIAGNOSTICS LTD. (IL) | 1986-10-08 | — | — | EP | claimed |
| EP-4532543-A1 | ANTI-BCMA ANTIBODIES | Sanofi (FR) | 2025-04-09 | — | — | EP | disclosed |
| US-20240350622-A1 | Vaccine Antigen | MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED (AU) | 2024-10-24 | — | — | US | disclosed |
| WO-2024177860-A1 | IN CHEMICO TEST FOR TOXICITY | LEBRUN LABS LLC (US) | 2024-08-29 | — | — | WO | disclosed |
| US-12018066-B1 | Compositions for targeting SARS-CoV-2 spike protein receptor binding domain | TRIAD NATIONAL SECURITY, LLC (US) | 2024-06-25 | — | — | US | disclosed |
| US-4525452-A | Enzyme immunoassay with step of immersing sample in deionized water | BTC DIAGNOSTICS LIMITED PARTNERSHIP (US) | 1985-06-25 | — | — | US | disclosed |
| US-4503143-A | Enzyme immunoassay with two-part solution of tetramethylbenzidine as chromogen | BTC DIAGNOSTICS LIMITED PARTNERSHIP (US) | 1985-03-05 | — | — | US | disclosed |
| EP-0071934-A1 | Method for preparing a color stable chromogenic analytical element | MILES LABORATORIES, INC. (US) | 1983-02-16 | — | — | EP | disclosed |
| US-4361648-A | POLYMERIC MORDANT, TETRAALKYLBENZIDINE HYDROCHLORIDE, ENZYME, PEROXIDATIVELY ACTIVE MATERIAL | MILES LABORATORIES, INC. (US) | 1982-11-30 | — | — | US | disclosed |